Product Launch (Blog)

Sep, 25 2020

Global Electronic Drug Delivery Systems Market is Expected to Grow at 8.9% in the Forecast Period of 2020 to 2027

Electronic Drug Delivery Systems Market is growing with factors such as high prevalence of various chronic disorders, along with the lack of skilled resources may obstruct the growth of the market in the given forecast period.  

Global Electronic Drug Delivery Systems Market Scenario                         

According to Data Bridge Market Research, the market for electronic drug delivery systems in North America region has the highest market share in global electronic drug delivery systems market. Market leader is Merck KGaA which accounts an estimated market share of approximately 21.94% .The Company has gained outstanding sale through providing electronic drug delivery devices.      

  • In October, 2017 Merck announced the first analysis result from easypod use in children with growth disorder which suggested the high adherence level to growth hormone. This data proves to be effective in making doctors and physicians utilize this device for drug administration which ultimately helped the company to boost its product sales.

Electronic Drug Delivery Systems MarketTrends Impacting the Market

Now the question is which other regions Merck KGaA, Novo Nordisk and Insulet Corporation  are targeting? Data Bridge Market Research has estimated a large growth in North America electronic drug delivery systems market and the market leaders targeting U.S. and Canada to be their next revenue pockets for 2020.  

The electronic drug delivery systems market is becoming more competitive with companies such as Merck KGaA, Novo Nordisk and Insulet Corporation as they are the top dominating companies in electronic drug delivery systems market having maximum number of products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global electronic drug delivery systems market.   

For more analysis on the global electronic drug delivery systems market request for a briefing with our analysts https://www.databridgemarketresearch.com/ar/speak-to-analyst/?dbmr=global-electronic-drug-delivery-systems-market

Global Electronic Drug Delivery Systems Market Development

  • In September 2019, Novo Nordisk and Medtronic entered into agreement in order to develop solutions to integrate insulin dosing data from Novo Nordisk smart insulin pens into continuous glucose monitoring provided by Medtronic. This collaboration helped the company to enhance its platform for electronic drug delivery system.

Scope of the Global Electronic Drug Delivery Systems Market

Global electronic drug delivery systems market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa

  • All country based analysis of global electronic drug delivery systems market is further analyzed based on further segmentation. Global electronic drug delivery systems market on the basis of  Type, the market is segmented into electronic infusion pumps, electronic injection pens,  electronic auto-injectors, electronic inhalers, electronic capsules, others. On the basis of  component, the market is segmented into  sensors, wireless communicator and antennas, micro pumps and flow regulators, drug reservoir, microcontroller, others. On the basis of connectivity, the market is segmented into bluetooth low energy (BLE), Wi-Fi, ethernet, NB-IoT, others. On the basis of system type, the market is segmented into battery-powered systems, rechargeable systems. On the basis of  application, the market is segmented into  diabetes, asthma and chronic obstructive pulmonary disease (COPD), multiple sclerosis, growth hormone therapy, immunodeficiency disease, cardiovascular disease, thalassemia, others. On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, ambulatory centers, others.

To know more about the study https://www.databridgemarketresearch.com/ar/reports/global-electronic-drug-delivery-systems-market

Key Pointers Covered in Global Electronic Drug Delivery Systems Market Industry Trends and Forecast to 2027

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of electronic drug delivery systems market
  • Company profiling of top eight players of electronic drug delivery systems market

Key Market Competitors Covered in the Report

  • AstraZeneca
  •  Amgen Inc
  •  Ypsomed AG
  •  Merck KGaA
  •  Bayer AG
  •  Nemera
  •  F. Hoffmann-La Roche Ltd
  •  Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
  • AptarGroup, Inc
  •  Novo Nordisk A/S
  •  ViCentra B.V
  •  Medtronic
  •  United Therapeutics Corporation
  •  Companion Medical
  •  Tandem Diabetes Care
  •  Debiotech S.A
  •  Canè SpA
  •  Insulet Corporation
  •  BD
  •  Findair Sp. z o. o
  •  B. Braun Melsungen AG
  •  West Pharmaceutical Services, Inc

Above are the key players covered in the report, to know about more and exhaustive list of electronic drug delivery systems companies’, contact us: https://www.databridgemarketresearch.com/ar/toc/?dbmr=global-electronic-drug-delivery-systems-market

Research Methodology: Global Electronic Drug Delivery Systems Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Anesthetist, Doctors, Surgeons, Healthcare Professionals
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/ar/report-category/healthcare/


Client Testimonials